n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, August 24th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Ecosphere Technologies, Inc. (ESPH)

TheMicrocapNews, PennyStocks24, Buzz Stocks, Penny Pick Finders, PennyStockProphet, SmallCapVoice, Wall Street Resources, Planet Penny Stocks, SecretStockPromo, and StockOnion reported earlier on Ecosphere Technologies, Inc. (ESPH), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ecosphere Technologies, Inc. is a development and Intellectual Property (IP) licensing company. It develops environmental solutions for global water, energy, industrial, and agricultural markets. The Company helps industry increase production, lessen costs, and protect the environment through a portfolio of inventive, patented technologies and exclusive and nonexclusive licensing opportunities across a wide spectrum of industries and applications globally. Ecosphere Technologies is based in Stuart, Florida.

Ecosphere has a wide-ranging portfolio of patented clean technologies. These can be purchased and licensed for use in large-scale and sustainable applications across industries, nations, and ecosystems. The Company’s technologies include the Ecos PowerCube®, the Ecos GrowCube™, and Ozonix®.

The Ecosphere technologies and products are available via many brands and subsidiaries. These include Sea of Green Systems, Ecosphere Development Company, and Fidelity National Environmental Solutions. The Company’s goal is to help clean energy producers’ gain more control over their water resources, quality, and completion costs through providing effective mobile water recycling solutions.

The Ecosphere Ozonix® Technology provides a chemical-free alternative to high-volume water recycling for a varied range of applications. These range from the oil & natural gas industry and mining to agriculture and municipal wastewater treatment. The oil and natural gas industry is successfully using Ecosphere Technologies’ patented Ozonix® technology to treat and recycle the water used in oil and natural gas well drilling and completion programs.

The Ecos PowerCube® is the world’s largest, mobile, solar-powered generator. It runs on high power photovoltaic panels. These panels extend from its container combined with an easy to set up wind turbine. Energy is stored in onboard batteries.  

The Ecos GrowCube® is a state-of-the-art, turn-key, fully-automated "greenhouse". It uses hydroponic growing techniques to maximize the amount of crop production possible in a given footprint. The Ecos GrowCube® incorporates Ecosphere’s patented Ozonix® water treatment technology. In addition, Ecosphere has its Ozonix Sentinel. This is the world's first line of water treatment vessels for cleaning up endangered rivers and lakes.

Sea of Green Systems (SOGS), a subsidiary of Ecosphere Technologies, announced in January 2017 the launch of its SOGS-650X, Full Spectrum LED Growing Light. This light was developed to provide growers with an engineered solution to maximize vegetative growth and flower production for the indoor agriculture and legal marijuana industries.

The SOGS-650X can produce greenhouse-like conditions through providing an average 25 DLI (Daily Light Integral) during the Vegetative and Flowering Cycles, with about 450-650 uMols and 700-900 uMols at the plant canopy during their respective growth cycles. Sea of Green Systems (SOGS) sells high-tech growing equipment, lighting solutions, and nutrients to the Precision Agriculture industry.

Yesterday, Sea of Green Systems announced that its sublicensee in the agricultural industry, Gulf Coast Organics (GCO), signed an agreement with Wedgworth's, Inc., to be the exclusive distributor in Florida for its Amp Agronomy™ plant nutritional line. Wedgworth's is recognized as Florida's largest custom fertilizer dealer since 1932. Wedgworth's provides custom blended agricultural plant nutrient products across Florida to help farms grow and prosper. CAVISONIX®, developed by SOGS and Ecosphere Technologies, utilizes ultrasonic cavitation to treat fertilizers for increased plant availability.

Ecosphere Technologies, Inc. (ESPH), closed Thursday's trading session at $0.0148, down 17.78%, on 335,483 volume with 21 trades. The average volume for the last 60 days is 159,999 and the stock's 52-week low/high is $0.0107/$0.0738.

International Western Petroleum, Inc. (INWP)

DreamTeamNetwork, Equities, and Stock News Now reported on International Western Petroleum, Inc. (INWP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

International Western Petroleum, Inc. is an E&P (Exploration & Production) company listed on the OTC Markets. It specializes in the acquisition, development, and exploration of crude oil and natural gas properties in Texas. It is working to acquire oil and gas properties. Moreover, it is working to apply the latest technologies and production techniques to boost acreage, productions, and reserves with a concentration in the Central West Texas area. International Western Petroleum has its headquarters in Irving, Texas.

The Company will be focusing on regional acquisition(s) with an emphasis in the Permian Basin region. Its area of interest is production locations within the Wolfcamp shale in the Midland Basin section of the Texas Permian Basin.

It has acquired, from its operating partner International Western Oil Corp., Working Interests (WI’s) of two oil and gas production fields having proven reserves of around 154 Mbbl oil and 120 MMcf natural gas in Recoverable Net Reserves (PV10 report) in Coleman County, Texas.

International Western Oil secured several concessions covering roughly 2,400 acres in the Central West Texas region. Outside the Central West Texas area and within the United States, the Company has accessibility to approximately 95,000 acres of large-reserve oil and gas concessions, now under Company management review for acquisition efforts.

In September of 2016, International Western Petroleum completed an acquisition of a producing oil field in Kilgore, Texas, via the Marshall Walden Joint Venture (JV), a partnership with Odyssey Enterprises, LLC. International Western Petroleum is the managing venturer in this JV with Odyssey. There are 8 wellbores in the acquisition -  4 now in production and 4 inactive.

International Western Petroleum is working with a technology company providing a state-of-the-art Organic Oil Recovery (OOR) process. This process can release trapped oil without exploration risks. International Western Petroleum has also started initial field works in its own productions. This is while exploring this new technology, beginning with the East Texas and Central West Texas areas.

International Western Petroleum has acquired a 3D Seismic leasehold in King County, Texas. This acquisition mainly includes a 350-acre leasehold in King County, with additional options to lease up to 800 acres of adjoining acreage with complete 3D seismic data.

International Western Petroleum has started a new acquisition model founded on the financed acquisition of mature oil fields, which have significant potential for the application of an Advanced Enhanced Oil Recovery (EOR) process, and also founded on strategic partnerships with existing operators to share production increases acquired through the implementation of this EOR process.

Earlier this month, International Western Petroleum announced that it sold in a private placement 34,500,000 shares of common stock to a number of investors. This includes Mr. Patrick Norris and a company controlled by him, JBB Partners, Inc. The Company received $345,000 from the sale of these shares. Additionally, JBB Partners lent International Western Petroleum an additional $550,000, modifying its existing loan originally made in April of this year.

Together the Company has obtained, before expenses, $895,000 in Working Capital. It expects to use the new funding for production improvement projects. Its aim is to execute its acquisition model with EOR (Enhanced Oil Recovery) methods applied to oil and gas properties. This is to speed up its production revenues and increase assets.

International Western Petroleum, Inc. (INWP), closed Thursday's trading session at $0.459, even for the day, on 3,000 volume with 2 trades. The average volume for the last 60 days is 12,486 and the stock's 52-week low/high is $0.20/$1.80.

Emerald Medical Applications Corp. (MRLA)

OTC Markets, MarketWatch, YCharts, Wall Street Journal, and Reuters reported on Emerald Medical Applications Corp. (MRLA), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Emerald Medical Applications Corp. is a medical technology enterprise listed on the OTC Markets. The Company uses proprietary military image processing technology and state-of-the-art data analytics to improve the analysis of medical images. Emerald engages in the development and sale of DermaCompare™. This is its proprietary Artificial Intelligence (AI) technology and application for the early diagnosis of melanoma and other skin cancers. Emerald Medical Applications is headquartered in Petach Tikva, Israel.

DermaCompare is the first application of Emerald Medical Applications’ technology and innovation. The Company’s technology uses the knowledge of military image processing and big data analytics to improve the analysis of medical images for the benefit of patients and the medical community. DermaCompare is a Food and Drug Administration (FDA) Class #1 approved, HIPPA-compliant, skin cancer (melanoma) screening platform.  

DermaCompare enables home use by using every smartphone. It applies AI and predictive analytics, and maps the ‘Melanoma Starting Point’. DermaCompare is a ground-breaking skin cancer screening platform. It enables physicians to identify and monitor changes in their patients’ skin characteristics.

DermaCompare enables patients to self-conduct a dermatology scan using Total Body Photography Imaging (TBP) taken with a digital camera, usually a tablet or Smartphone (iPhone or Android). The application (App) and instructions can be downloaded on almost any device with a digital camera. DermaCompare provides actionable pieces of information, higher quality with reduced costs, and is aligned with population health management initiatives taken by governments globally.

Upon a patient uploading their TBP images to their file in the DermaCompare cloud for storage and review, the DermaCompare platform compares those images to any prior patient images on file, and also any relevant images from Emerald’s database. In addition, the DermaCompare platform updates the patient file and creates a summary of data points with current, relevant data regarding the patient's skin images together with alerts to any suspicious image changes. The DermaCompare platform also notifies the associated physician to retrieve and review the patient's chart and TPB images.

DermaCompare integrates augmented reality. This permits physicians to review the patient’s skin, using their smartphone or Google Glass. The platform will provide for the first time an international multi-dimensional database of the human skin accessible anytime, anywhere. Emerald’s technology originated from the concepts applied by the Israeli Air Force and the intelligence services who utilize auto aerial photo diagnostics to track collateral damage after engaging the enemy. This means that the technology can detect and compare changes in imagery and subsequently conduct analysis and comparison at a very high precision level. Now, Emerald Medical Applications has applied it to facilitate the early detection and diagnostics of skin cancer -  to prevent and cure it.

This past March, Emerald Medical Applications announced that Publicis Groupe completed the purchase of 1,315,563 shares of Emerald's common stock, representing a total investment of $526,225.20, based upon the agreed purchase price of $0.40 per share.

Publicis Groupe's investment in Emerald was made after considerable due diligence regarding Emerald and its DermaCompare™ skin cancer screening application. Publicis Groupe’s investment in Emerald was the result of Emerald being awarded the Grand Prize of 500,000 Euros over 3,500 other competing technology companies at Publicis Groupe's "Publicis 90" Initiative at the Viva Technology event held in Paris, France in early July of 2016, after being selected.

Emerald Medical Applications Corp. (MRLA), closed Thursday's trading session at $0.0469, even for the day. The average volume for the last 60 days is 21,579 and the stock's 52-week low/high is $0.04/$0.51.

NuLife Sciences, Inc. (NULF)

Investors Hub, CNA Finance, and MarketWatch reported on NuLife Sciences, Inc. (NULF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

NuLife Sciences, Inc. centers on advancing human organ transplant technology and medical research.  A biomedical enterprise, the Company has a patent protected innovative proprietary method (the NuLife Technique). It focuses on medical research and technology, which has the potential to address major unmet medical needs in applications including transplantation/regenerative medicine/cell therapy/organ and tissue transplants.

Formed in 2013, NuLife Sciences is based in San Clemente, California. The Company previously went by the name SmooFi, Inc. It changed its name to NuLife Sciences, Inc. in December of last year. NuLife Sciences’ wholly-owned subsidiary is NuLife BioMed, Inc.

Mr. John Hollister, Chief Executive Officer (CEO) of NuLife Sciences, said in December of 2016, "We are moving forward as NuLife Sciences, a name that better reflects our focus on a unique patented proprietary method, the 'NuLife Technique', that could potentially eliminate the need for an organ or tissue match and the necessity for anti-rejection drugs in human organ transplant. With the Discovery phase completed, we now intend to enter a Preclinical phase involving animal experiments in collaboration with Florida International University and Nova Southeastern University.”

NuLife’s technique is versatile and is suitable for a variety of clinical indications. The NuLife Technique was developed through 15 years of dedicated research. The result has been many breakthroughs in hematopoietic research and transplant techniques. The objective of the research was to address the issues of organ compatibility and the need for anti-rejection drugs in the donor. NuLife Sciences has wide-ranging patent and Intellectual Property (IP) protections in place.

Recently, NuLife Sciences, by way of its wholly-owned subsidiary, NuLife BioMed, announced that it moved into space at Nova Southeastern University's (NSU) prestigious Center for Collaborative Research (CCR). This is where it will conduct research on the NuLife Technique, the aforementioned means to potentially eliminate the requirement for tissue matching between donor and recipient in kidney transplants and the need for anti-rejection medication post-surgery.

NuLife leased 350 square feet of space in the new, state-of-the-art facility. This facility offers collaboration with NSU's expert researchers and access to the CCR's sophisticated equipment, technology, and laboratories.

Last week, NuLife Sciences, via NuLife BioMed, announced it started a pre-clinical trial on the NuLife Technique. The trial began on August 8, 2017 at Florida International University. This trial will evaluate the NuLife process in an autologous setting, meaning an organ is removed from and transplanted back to the same donor. The goal of this study is to prove that the NuLife Technique is viable.

NuLife Sciences, Inc. (NULF), closed Thursday's trading session at $0.60, even for the day, on 5,300 volume with 2 trades. The average volume for the last 60 days is 2,375 and the stock's 52-week low/high is $0.12/$1.50.

Continental Energy Corp. (CPPXF)

TopPennyStockMovers, Streetwise Reports, and Agoracom reported previously on Continental Energy Corp. (CPPXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Continental Energy Corp. is an emerging developer of conventional and alternative energy capacity integrated with upstream and downstream petroleum supply within the Republic of Indonesia. Listed on the OTC Markets, the Company’s commitment is to developing hybrid renewable electrical power generation capacity and profitably operating mini-grid distribution networks in the huge, under-served markets of the fast-growing economies encircling the Indian Ocean Rim.

Established in 1984, Continental Energy is headquartered in Vancouver, British Columbia. The Company previously went by the name Continental Copper Corp. It changed its corporate name to Continental Energy Corp. in October of 1997.

The Company’s core competency exists in Indonesia. It has 30 years of experience in Indonesia. This has given Continental Energy the business relationships and local operating experience necessary to capitalize on the rising energy demand in this country.

In addition, Continental Energy has its business combination with the Ruaha River Power Company. This business combination provided instant entry into Tanzania. This is where the best-in-Africa commercial incentives for small scale renewable energy developers are in place to foster new supply of power to off-grid communities.

Last week, Continental Energy announced the filing on SEDAR of its audited consolidated financial statements and its management discussion and analysis for its Fiscal 2017 year ended June 30, 2017. Continental had a Loss from Operations of $439,606 during Fiscal 2017 versus a Loss from Operations of $473,289 during Fiscal 2016. This represents a decrease of $33,683, mainly because of lower professional fees and share-based payments.

The Company had a loss per share of $0.00 in both 2017 and 2016. Continental’s administrative costs were lower by $14,428 in 2017 versus 2016. This was chiefly because of reduced professional fees: 2017 - $376,842; and 2016 - $391,270. As at the end of this Fiscal Year 2017, Continental Energy’s Working Capital deficit was $1,721,256 versus a Working Capital deficit of $1,282,380 at the end of Fiscal 2016.

Continental Energy Corp. (CPPXF), closed Thursday's trading session at $0.047, even for the day. The average volume for the last 60 days is 19,762 and the stock's 52-week low/high is $0.0026/$0.08.

graphic

The QualityStocks
Company Corner

graphic
graphic

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.05872, up 6.76%, on 4,774,671 volume with 322 trades. The stock’s average daily volume over the past 60 days is 5,156,619, and its 52-week low/high is $0.002/$0.0995.

PotNetwork Holding, Inc. (POTN), today announced that as part of its strategy to formulate, produce and market a spectrum of exclusive and diversely targeted cannabidiol blends, the Company has added Dr. David M. Feldbaum MD, FACS to its Board of Advisors. Dr. Feldbaum is certified in vascular surgery by the American Board of Surgery. He completed a surgical residency at Montefiore Medical Center/Albert Einstein College of Medicine in New York City, as well as a vascular surgery fellowship at the Carolinas Heart Institute in North Carolina. Dr. Feldbaum is affiliated with the Memorial Healthcare System and the Westside Regional Medical Center, and is also a member of the voluntary faculty clinical instructor of surgery at the University Of Miami School Of Medicine.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

With Revenues over $1,459,137, PotNetwork Holding, Inc.’s Diamond CBD Continues to Exceed Projections, Bringing in the Highest Level of Monthly Sales to Date

PotNetwork Holding, Inc. Strengthens Board of Advisors with the Appointment of Dr. David Feldbaum

PotNetwork Holdings, Inc. Senior Advisor, Bruce Barren, is now Featured in a New Audio Interview at SmallCapVoice.com

AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.01087, up 18.15%, on 121,646 volume with 8 trades. The stock’s average daily volume over the past 60 days is 227,620 and its 52-week low/high is $0.002/$0.25.

AppSwarm, Inc. (SWRM), a technology development and publishing company that also includes incubation acceleration by partnering with app developers, announces that it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

AppSwarm, Inc. (SWRM) Engages NetworkNewsWire for Corporate Communications Solutions

AppSwarm Announces Acquisition of Multiplatform Games Developer and Publisher MediaPlay and the Creation of Two Divisions of AppSwarm, Inc.

AppSwarm, Inc. (SWRM) Ahead of the Game as It Seeks to Increase Choice for More than 2 Billion Players

ABcann Global (TSX.V:ABCN) (OTCQB:ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF). Today, ABcann Global closed trading at $0.732, up 2.64%, on 202,434 volume with 194 trades. The stock’s average daily volume over the past 60 days is 63,760 and its 52-week low/high is $0.6171/$0.90.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global (TSX VENTURE: ABCN) (OTCQB: ABCCF), a client of NNW that is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. The publication, titled, "As Recreational Cannabis Legalization Looms, the Field of Opportunity is Green for Canada's Leading Growers," discusses the legislation introduced by the Canadian government to permit recreational cannabis use, and the companies preparing for an even larger market. To view the full publication, visit: https://www.networknewswire.com/recreational-cannabis-legalization-looms-field-opportunity-green-canadas-leading-growers/

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) ABcann Medicinals, Inc. is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. One of the earliest licensed Canadian medical marijuana producers under Canada's federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space. The company currently owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario. Additionally, ABcann owns 65 acres of real estate with proper zoning and existing infrastructure in place to support the construction of another production facility of up to one million square feet.

In a November 2016 report, market research firm Canaccord Genuity Group forecasted that the medical marijuana market in Canada could see sales in excess of $8 billion by 2024, creating a sizable opportunity for the country's licensed producers (LPs). The research firm also noted that the "rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry and there will be a shortfall of supply in a legalized market in the short-term." This market barrier serves as a strategic advantage for ABcann as it prepares for its highly-anticipated IPO, which is currently scheduled for April 2017.

Canaccord's synopsis of the Canadian cannabis industry is supported by recent market activity, as companies sporting one of the illustrious Canadian government licenses for medicinal production have recorded strong growth following IPO. Canopy Growth (OTC: TWMJ), one of the largest fully-licensed Canadian marijuana growers, saw share prices skyrocket by more than 700 percent in the months following its initial offering. Aphria Inc. (OTC: APHQF), another licensed grower, climbed by more than 900 percent following its IPO. Other companies that have recorded huge growth since going public include Aurora Cannabis (OTC: ACBFF), climbing nearly 900 percent, and SupremePharma (OTC: SPRWF), which soared more than 1,300 percent.

With these market trends in mind, ABcann's impending IPO is one that prospective investors in the marijuana sector will want to explore. Recalls from some of the biggest players in the Canadian cannabis industry have highlighted the considerable learning curve that LPs face in today's market, which makes ABcann's proven track record in the market all the more noteworthy. The company has built a reputation over the years for its best-in-class standardized approach to growing cannabis, including the thoughtful omission of pesticides and a computer monitored growing technique that allows ABcann to minimize the risks of variance in its yields and ensure the creation of consistently high-quality products.

This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann's current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry. This global growth potential is illustrated by ABcann's partnership with Israel's Syqe Medical, producer of the world's first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting the company's production facility, Perry Davidson, founder of Syqe Medical, noted that ABcann's production technologies put it "in a class with the best in the world" in its ability to produce standardized pharmaceutical grade cannabis.

ABcann's entry into the public sector is being guided by a seasoned management team, board of directors and advisory board that feature well over a century of combined industry experience. Ken Clement, the company' founder and executive chairman, has been the key component and driving force behind ABcann's development since its inception. His vision of standardized production and dosage sets ABcann apart in the medical cannabis sector. Clement is joined on the company's management team by CEO Aaron Keay. Keay brings more than a decade of capital markets experience to ABcann, having played a role in raising approximately $250 million for public and private market issuers.

Notably, ABcann also has access to the 'Father of Cannabis Research', Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC), and he has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well-positioned to compete in the rapidly-expanding Canadian medicinal cannabis industry. These factors, along with the company's ongoing global expansion into the European, Australian and Israeli markets, show why ABcann Medicinals' upcoming public offering fits the bill as "Canada's Next Medical Marijuana IPO." Disclaimer

ABcann Global Blog

ABcann Global News:

NetworkNewsWire Announces Publication Discussing Canadian Cannabis Investment Options

NetworkNewsWire Announces Publication on Canada's Top Cannabis Companies

NetworkNewsWire Announces Publication Discussing Public Companies Aiming to Take Advantage of Canada's Legal Marijuana Market

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0795, off by 11.67%, on 41,457,428 volume with 2,141 trades. The stock’s average daily volume over the past 60 days is 20,845,252, and its 52-week low/high is $0.0075/$0.415.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring SinglePoint, Inc. (SING), a client of NNW focused on strengthening its position in the marijuana industry through the acquisition of, or investment in, small to mid-sized cannabis companies. The publication, titled, "Cannabis and Cryptocurrency: The Time Is Now," discusses the how the lack of banking options has resulted in the use of cryptocurrencies in the cannabis sector. To view the full publication, visit: https://www.networknewswire.com/cannabis-cryptocurrency-time-now/

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

NetworkNewsWire Announces Publication Discussing the Application of Bitcoin to the Cannabis Sector

NetworkNewsWire Announces Publication Highlighting the Intersection of Cannabis and Cryptocurrency

SinglePoint Continues Accelerated Growth in Cannabis Sector with Letter of Intent to Acquire Dr. FeelGood

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.11, up 22.22%, on 46,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 9,286 and its 52-week low/high is $0.0001/$0.62.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

Algae Dynamics Corp Enters Into a Letter of Intent with Bonify to Produce Unique Cannabis Oil Products; Accelerates Go-to-Market Strategy

NetworkNewsWire Releases Exclusive Audio Interview with Algae Dynamics Corp. (ADYNF)

Algae Dynamics Corp. (ADYNF) Engages NetworkNewsWire for Corporate Communications Solutions

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Trader Power News
(CDNA) +33.02%

2.

QualityStocks
(IDDR) +30.49%

3.

MarketBeat
(ADPTQ) +23.47%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251